Wikisage, the free encyclopedia of the second generation, is digital heritage
Valproate XR: Difference between revisions
Jump to navigation
Jump to search
m (rfz) |
No edit summary |
||
| Line 2: | Line 2: | ||
The patients had significantly less lateral effects (e.g. headaches, tremor of hands, and gastric upset a aggression were less) | The patients had significantly less lateral effects (e.g. headaches, tremor of hands, and gastric upset a aggression were less) | ||
<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771963/ Immediate switching from a chrono to an extended-release formulation of divalproex sodium: A two-part study in patients with controlled epilepsy]</ref> | <ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771963/ Immediate switching from a chrono to an extended-release formulation of divalproex sodium: A two-part study in patients with controlled epilepsy]</ref> | ||
==Links== | |||
Leppik & Hovinga | |||
[http://onlinelibrary.wiley.com/doi/10.1111/epi.12043/epdf Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations] epilepsia 54(2013) | |||
<references/> | <references/> | ||
Revision as of 04:05, 1 July 2016
improved compliance was observed with valproic acid and divalproex sodium[1] The patients had significantly less lateral effects (e.g. headaches, tremor of hands, and gastric upset a aggression were less) [2]
Links
Leppik & Hovinga Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations epilepsia 54(2013)